Financial Ratios

DISHMAN CARBOGEN AMCIS LTD.

NSE : DCALBSE : 540701ISIN CODE : INE385W01011Industry : Pharmaceuticals & DrugsHouse : Dishman Pharma
BSE221.251.95 (+0.89 %)
PREV CLOSE ( ) 219.30
OPEN PRICE ( ) 214.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 32616
TODAY'S LOW / HIGH ( )213.45 224.15
52 WK LOW / HIGH ( )113.25 282.95
NSE221.051.5 (+0.68 %)
PREV CLOSE( ) 219.55
OPEN PRICE ( ) 217.00
BID PRICE (QTY) 221.05 (53)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 383540
TODAY'S LOW / HIGH( ) 213.40 224.15
52 WK LOW / HIGH ( )113.1 283
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)-3.75-1.94-14.422.463.47
   CEPS(Rs)2.386.99-5.4111.4211.92
   DPS(Rs)0.000.000.000.000.20
   Book NAV/Share(Rs)262.39269.88298.13305.66303.12
   Tax Rate(%)38.8063.43-39.5830.5431.47
Margin Ratios
   Core EBITDA Margin(%)1.9311.02-26.3529.8935.27
   EBIT Margin(%)-9.51-15.03-63.8217.6523.51
   Pre Tax Margin(%)-23.90-27.17-80.889.5514.87
   PAT Margin (%)-14.62-9.94-112.896.6310.19
   Cash Profit Margin (%)9.2735.75-42.3330.8535.00
Performance Ratios
   ROA(%)-1.10-0.55-3.900.660.95
   ROE(%)-1.41-0.68-4.780.801.16
   ROCE(%)-0.81-0.93-2.421.892.37
   Asset Turnover(x)0.080.060.030.100.09
   Sales/Fixed Asset(x)0.170.130.090.250.24
   Working Capital/Sales(x)50.261.431.044.032.61
Efficiency Ratios
   Fixed Capital/Sales(x)5.967.6711.753.994.17
   Receivable days96.32109.85240.3286.4489.73
   Inventory Days172.08226.96362.63137.09130.10
   Payable days148.22198.71262.47163.79204.11
Valuation Parameters
   PER(x)0.000.000.0021.8360.34
   PCE(x)52.3826.49-20.164.6917.57
   Price/Book(x)0.480.690.370.180.69
   Yield(%)0.000.000.000.000.10
   EV/Net Sales(x)6.1510.9110.762.307.13
   EV/Core EBITDA(x)41.3333.47159.635.4814.75
   EV/EBIT(x)-64.70-72.56-16.8613.0130.32
   EV/CE(x)0.460.620.380.250.72
   M Cap / Sales4.869.478.531.456.15
Growth Ratio
   Net Sales Growth(%)31.2953.06-65.515.6915.81
   Core EBITDA Growth(%)-40.02640.00-94.45-8.4214.45
   EBIT Growth(%)16.9363.96-224.76-20.6632.46
   PAT Growth(%)-93.2186.53-687.07-31.2351.09
   EPS Growth(%)-93.2186.53-687.45-29.2551.09
Financial Stability Ratios
   Total Debt/Equity(x)0.140.120.110.120.12
   Current Ratio(x)1.011.391.361.231.40
   Quick Ratio(x)0.731.031.010.890.98
   Interest Cover(x)-0.66-1.24-3.742.182.72
   Total Debt/Mcap(x)0.300.180.310.660.17

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.